Implication of JAK1, JAK2, and JAK3 in the Realization of Proliferation and Differentiation Potential of Mesenchymal Progenitor Cells In Vitro

被引:3
|
作者
Zyuz'kov, G. N. [1 ,2 ]
Zhdanov, V. V. [1 ]
Udut, E. V. [1 ]
Miroshnichenko, L. A. [1 ]
Simanina, E. V. [1 ]
Polyakova, T. Yu. [1 ]
Chaikovskii, A. V. [1 ]
Stavrova, L. A. [1 ]
Udut, V. V. [2 ]
Agafonov, V. I. [1 ]
Burmina, Ya. V. [1 ]
Danilets, M. G. [1 ]
Minakova, M. Yu. [1 ]
Dygai, A. M. [1 ]
机构
[1] ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
[2] Natl Res Tomsk State Univ, Tomsk, Russia
关键词
signal pathways; JAK kinases; progenitor cells; regenerative medicine; pharmacological control; COLONY-STIMULATING FACTOR; FUNCTIONAL STIMULATION; ALKALOID SONGORINE; PRECURSOR CELLS; BRAIN ISCHEMIA; HYALURONIDASE; MECHANISMS; STATS; Z77;
D O I
10.1007/s10517-016-3381-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Involvement of individual JAK kinases in the realization of growth potential of mesenchymal progenitor cells was examined in vitro. Important role of JAK2 and JAK3 in determining the initial level of mitotic activity of progenitor cells was established. The yield of fibroblast CFUF was suppressed under the effect of specific inhibitors of JAK kinases. Blockade of JAK3 increased the rate of progenitor element differentiation. JAK1 had no effect on proliferation and differentiation status of progenitor cells.
引用
收藏
页码:224 / 227
页数:4
相关论文
共 50 条
  • [1] Implication of JAK1, JAK2, and JAK3 in the Realization of Proliferation and Differentiation Potential of Mesenchymal Progenitor Cells In Vitro
    G. N. Zyuz’kov
    V. V. Zhdanov
    E. V. Udut
    L. A. Miroshnichenko
    E. V. Simanina
    T. Yu. Polyakova
    A. V. Chaikovskii
    L. A. Stavrova
    V. V. Udut
    V. I. Agafonov
    Ya. V. Burmina
    M. G. Danilets
    M. Yu. Minakova
    A. M. Dygai
    Bulletin of Experimental Biology and Medicine, 2016, 161 : 224 - 227
  • [2] Involvement of JAK1, JAK2, and JAK3 in Stimulation of Functional Activity of Mesenchymal Progenitor Cells by Fibroblast Growth Factor
    Zyuz'kov, G. N.
    Zhdanov, V. V.
    Udut, E. V.
    Miroshnichenko, L. A.
    Simanina, E. V.
    Polyakova, T. Yu.
    Stavrova, L. A.
    Udut, V. V.
    Minakova, M. Yu.
    Dygai, A. M.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 162 (02) : 240 - 243
  • [3] Involvement of JAK1, JAK2, and JAK3 in Stimulation of Functional Activity of Mesenchymal Progenitor Cells by Fibroblast Growth Factor
    G. N. Zyuz’kov
    V. V. Zhdanov
    E. V. Udut
    L. A. Miroshnichenko
    E. V. Simanina
    T. Yu. Polyakova
    L. A. Stavrova
    V. V. Udut
    M. Yu. Minakova
    A. M. Dygai
    Bulletin of Experimental Biology and Medicine, 2016, 162 : 240 - 243
  • [4] Role of JAK1, JAK2, and JAK3 in Functional Stimulation of Mesenchymal Precursor Cells by Alkaloid Songorine
    G. N. Zyuz’kov
    E. V. Udut
    L. A. Miroshnichenko
    E. V. Simanina
    T. Yu. Polyakova
    L. A. Stavrova
    V. V. Udut
    M. Yu. Minakova
    A. M. Dygai
    A. V. Chaikovskii
    V. I. Agafonov
    V. V. Zhdanov
    Bulletin of Experimental Biology and Medicine, 2017, 163 : 443 - 446
  • [5] Role of JAK1, JAK2, and JAK3 in Functional Stimulation of Mesenchymal Precursor Cells by Alkaloid Songorine
    Zyuz'kov, G. N.
    Udut, E. V.
    Miroshnichenko, L. A.
    Simanina, E. V.
    Polyakova, T. Yu.
    Stavrova, L. A.
    Udut, V. V.
    Minakova, M. Yu.
    Dygai, A. M.
    Chaikovskii, A. V.
    Agafonov, V. I.
    Zhdanov, V. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 163 (04) : 443 - 446
  • [6] Cooperating JAK1 and JAK3 mutants increase resistance to JAK inhibitors
    Springuel, Lorraine
    Hornakova, Tekla
    Losdyck, Elisabeth
    Lambert, Fanny
    Leroy, Emilie
    Constantinescu, Stefan N.
    Flex, Elisabetta
    Tartaglia, Marco
    Knoops, Laurent
    Renauld, Jean-Christophe
    BLOOD, 2014, 124 (26) : 3924 - 3931
  • [7] Blocking JAK1/JAK2 While Sparing JAK3 Not Only Prevents GvHD but Also Promotes Damaged Tissue Repair
    Ashami, Kidist
    Kim, Sena
    Vij, Ravi
    Ritchey, Julie K.
    Santhanam, Srikanth
    Lim, Sora
    Peterson, Sarah
    Ciorba, Matthew
    DiPersio, John F.
    Choi, Jaebok
    BLOOD, 2019, 134
  • [8] DEVELOPMENT OF A JAK3 SPECIFIC INHIBITOR CLINICAL CANDIDATE: FUNCTIONAL DIFFERENTIATION OF JAK3 SELECTIVE INHIBITION OVER PAN-JAK OR JAK1 SELECTIVE INHIBITION
    Telliez, J. -B.
    Wang, L.
    Jussif, J.
    Lin, T. H.
    Li, L.
    Moy, E.
    Li, W.
    Zhao, Y.
    Crouse, K.
    Symanowicz, P.
    Hegen, M.
    Banker, M. E.
    Vincent, F.
    Clark, J. D.
    Thorarensen, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 114 - 115
  • [9] Diamino-1,2,4-triazole derivatives are selective inhibitors of TYK2 and JAK1 over JAK2 and JAK3
    Malerich, Jeremiah P.
    Lam, Jennifer S.
    Hart, Barry
    Fine, Richard M.
    Klebansky, Boris
    Tanga, Mary J.
    D'Andrea, Annalisa
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7454 - 7457
  • [10] Complete genomic organization and promoter analysis of the round-spotted pufferfish JAK1, JAK2, JAK3, and TYK2 genes
    Leu, JH
    Yan, SJ
    Lee, TF
    Chou, CM
    Chen, ST
    Hwang, PP
    Chou, CK
    Huang, CJ
    DNA AND CELL BIOLOGY, 2000, 19 (07) : 431 - 446